Hillman Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hillman Capital Management's PFE Position: Q3 2026 in Review
Hillman Capital Management reduced its Pfizer (PFE) stake by 0.68% in Q3 2026, selling an estimated $31.4K and leaving 173,430 shares worth $4.95M. The position accounts for 3.7% of the portfolio, ranked #4.
Hillman Capital Management first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. The position peaked at $8.49M in Q4 2024. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Hillman Capital Management held 173,430 shares of Pfizer worth $4.95M as of Q3 2026.
- Hillman Capital Management sold 1,180 Pfizer shares in Q3 2026, an estimated $31.4K.
- Pfizer made up 3.7% of Hillman Capital Management's portfolio in Q3 2026, its #4 holding.
- Hillman Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
- Hillman Capital Management's Pfizer position peaked at $8.49M in Q4 2024.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Hillman Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.